WallStreetZenWallStreetZen

NASDAQ: ACAD
Acadia Pharmaceuticals Inc Stock Ownership - Who owns Acadia Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Acadia Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James KiharaPRINCIPAL ACCOUNTING OFFICER2026-05-265,401$21.18
$114.39kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2026-05-043,506$21.79
$76.40kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2026-05-041,332$21.79
$29.02kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2026-04-071,030$22.20
$22.87kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2026-04-072,709$22.20
$60.14kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2026-03-263,171$21.65
$68.65kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2026-03-261,097$21.65
$23.75kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2026-03-2612$21.73
$260.70Sell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2026-03-2637$21.72
$803.53Sell
Adams Catherine OwenChief Executive Officer2026-03-2511,641$21.47
$249.93kSell

1 of 3

ACAD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACAD insiders and whales buy or sell their stock.

ACAD Shareholders

What type of owners hold Acadia Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP25.05%42,896,690$931.72MInstitution
Baker Bros Advisors LP23.06%39,487,463$857.67MInsider
Blackrock Inc12.59%21,550,921$468.09MInstitution
Baker Brothers Life Sciences LP8.31%14,229,612$309.07MInsider
Vanguard Portfolio Management LLC5.06%8,671,645$188.35MInstitution
State Street Corp4.87%8,332,771$180.99MInstitution
Rtw Investments LP4.17%7,144,524$155.18MInstitution
Vanguard Capital Management LLC3.31%5,661,400$122.97MInstitution
Geode Capital Management LLC2.02%3,464,689$75.25MInstitution
First Trust Advisors LP1.95%3,343,868$72.63MInstitution

1 of 3

ACAD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACAD71.81%28.19%Net SellingNet Selling
NAMS75.24%24.76%Net SellingNet Selling
ERAS76.07%23.93%Net BuyingNet Buying
KNSA59.03%10.53%Net SellingNet Selling
ORKA25.54%74.46%Net BuyingNet Selling
View Top Biotech Stocks

Acadia Pharmaceuticals Stock Ownership FAQ

Who owns Acadia Pharmaceuticals?

Acadia Pharmaceuticals (NASDAQ: ACAD) is owned by 96.21% institutional shareholders, 37.77% Acadia Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Acadia Pharmaceuticals shareholder, owning 39.49M shares representing 23.06% of the company. Baker Bros Advisors LP's Acadia Pharmaceuticals shares are currently valued at $851.35M.

If you're new to stock investing, here's how to buy Acadia Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.